Table 1.
The clinical characteristics of patients with Graves' disease and healthy controls
| Variable | HC | GD in active | GD in remission | Normal range |
|---|---|---|---|---|
| No. | 30 | 30 | 16 | — |
| Age (y) | 37 ± 8 | 30 ± 9 | 36 ± 5 | — |
| Gender (M/F) | 4/26 | 5/25 | 3/13 | — |
| TSH (mIU/L) | 1.96 ± 0.27 | 0.007 ± 0.01 | 2.34 ± 0.35 | 0.35‐4.94 |
| FT4 (pmol/L) | 13.4 ± 1.54 | 46.02 ± 14.7 | 15.79 ± 2.15 | 9.01‐19.05 |
| FT3 (pmol/L) | 3.18 ± 0.55 | 34.3 ± 6.90 | 3.96 ± 0.71 | 2.63‐5.70 |
| TRAb (IU/L) | — | 27.9 ± 9.52 | 2.3 ± 0.43 | 0‐1.75 |
| TPOAb (IU/mL) | 5.03 ± 0.17 | 167.5 ± 23.23 | 24.3 ± 11.62 | 0.11‐5.23 |
| TgAb (IU/mL) | 2.54 ± 0.36 | 192.28 ± 17.32 | 47.12 ± 15.97 | 0.81‐3.83 |
Data are expressed as means ± standard deviation. M, male; F, female. “—” represents that the experiment was not performed, or the data are not applicable.
Abbreviation(s): GD, Graves' disease; HC, healthy controls.